» Authors » Xueyu Dai

Xueyu Dai

Explore the profile of Xueyu Dai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 392
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang Q, Tian N, Zhang J, Song S, Cheng H, Liu X, et al.
J Clin Invest . 2025 Feb; 135(4). PMID: 39959978
No abstract available.
2.
Huang Q, Tian N, Zhang J, Song S, Cheng H, Liu X, et al.
J Clin Invest . 2024 Oct; 134(23). PMID: 39446493
Ku70, a DNA repair protein, binds to the damaged DNA ends and orchestrates the recruitment of other proteins to facilitate repair of DNA double-strand breaks. Besides its essential role in...
3.
Jiang Z, Huang Q, Chang Y, Qiu Y, Cheng H, Yang M, et al.
Cell Oncol (Dordr) . 2024 Apr; 47(5):1679-1696. PMID: 38656573
Purpose: Increased expression of leukocyte immunoglobulin-like receptor subfamily B member 2 (LILRB2) is associated with immune evasion in breast cancer (BC). The aim of this study to elucidate the role...
4.
Yin H, Distler O, Shen L, Xu X, Yuan Y, Li R, et al.
Arthritis Rheumatol . 2023 Jul; 76(1):78-91. PMID: 37488975
Objective: Interferon (IFN)-1 signatures are a hallmark of patients with systemic sclerosis (SSc). However, its significance in clinical stratification and contribution to deterioration still need to be better understood. Methods:...
5.
Tang X, Deng B, Zang A, He X, Zhou Y, Wang D, et al.
Front Immunol . 2022 Oct; 13:940577. PMID: 36248873
Background: Aging is usually accompanied by functional declines of the immune system, especially in T-cell responses. However, little is known about ways to alleviate this. Methods: Here, 37 middle-aged healthy...
6.
Xu Z, Jiang X, Dai X, Li B
Front Immunol . 2022 Jul; 13:916411. PMID: 35874688
Coronavirus disease 2019 (COVID-19) has been raging all around the world since the beginning of 2020, and leads to acute respiratory distress syndrome (ARDS) with strong cytokine storm which contributes...
7.
Deng B, Yang B, Chen J, Wang S, Zhang W, Guo Y, et al.
J Immunother Cancer . 2022 Jul; 10(7). PMID: 35817479
Background: Foxp3 regulatory T (T) cells facilitate tumor immune evasion by forming a suppressive tumor microenvironment. Therefore, immune therapies promoting T fragility may greatly enhance immune checkpoint blockade (ICB) efficacy...
8.
Yang M, Li D, Jiang Z, Li C, Ji S, Sun J, et al.
Mol Cancer Res . 2022 May; 20(8):1247-1259. PMID: 35560224
Implications: CAFs enhance colorectal cancer aggressiveness by reducing FLRT3 expression through activating TGF-β/SMAD4 signaling pathway. CAF-targeted therapy and/or LY2109761 were promising treatments for colorectal cancer.
9.
Liu Y, Huang Q, Du J, Huang C, Li D, Dai X, et al.
Clin Transl Med . 2021 Nov; 11(11):e590. PMID: 34841691
No abstract available.
10.
Zhang W, Liu X, Zhu Y, Liu X, Gu Y, Dai X, et al.
Eur J Immunol . 2021 Jul; 51(9):2137-2150. PMID: 34322865
Regulatory T (Treg) cells and T helper type 17 (Th17) cells play important roles in adaptive immune responses, antagonizing each other in immune disorders. Th17/Treg balance is critical to maintaining...